Michael J. LaBarre - 15 Feb 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role: SVP, CHIEF TECHNICAL OFFICER
Signature: /s/ James R. Oehler, Attorney-in-Fact
Issuer symbol: HALO
Transactions as of: 15 Feb 2023
Net transactions value: -$541,504
Form type: 4
Filing time: 17 Feb 2023, 05:29:03 UTC
Previous filing: 14 Feb 2023
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HALO	Common Stock	Sale	$483,940	-10,000	-6.5%	$48.39	143,477	15 Feb 2023	Direct	F1
transaction	HALO	Common Stock	Options Exercise	$0	+3,386	+2.4%	$0.000000	146,863	15 Feb 2023	Direct
transaction	HALO	Common Stock	Tax liability	$57,564	-1,170	-0.8%	$49.20	145,693	15 Feb 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HALO	Restricted Stock Units	Options Exercise	$0	-3,386	-33%	$0.000000	6,772	15 Feb 2023	Common Stock	3,386	$0.000000	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The reported disposition of 1,170 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3	This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.